TGFB1 and breast carcinoma: Ad.sTβRFc is an Ad5-based oncolytic adenovirus expressing soluble transforming growth factor beta receptor II-Fc fusion protein (sTGFβRIIFc), a protein that directly targets TGF-β and inhibits TGF-β signaling, and was first used in preclinical studies of breast cancer [175,176].